Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Yabuno

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Gynecologic Oncology|November 13, 2020
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 TrialTakashi Motohashi, Akira Yabuno, Hiroshi Michimae, et al.
Gynecologic Oncology|January 9, 2019
Association of statins, aspirin, and venous thromboembolism in women with endometrial cancerKoji Matsuo, Marianne S Hom, Akira Yabuno, et al.
Scientific Reports|October 29, 2020
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinomaAkira Yabuno, Hirokazu Matsushita, Tetsutaro Hamano, et al.
Gynecologic Oncology|April 2, 2018
Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancerKoji Matsuo, Akira Yabuno, Marianne S Hom, et al.
Gynecologic Oncology|May 29, 2020
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275Julian C Schink, Virginia Filiaci, Helen Q Huang, et al.
Journal for Immunotherapy of Cancer|May 29, 2020
Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinomaHirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, et al.
Gynecologic Oncology|August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerKoji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Gynecologic Oncology|November 13, 2020
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 TrialTakashi Motohashi, Akira Yabuno, Hiroshi Michimae, et al.
Gynecologic Oncology|January 9, 2019
Association of statins, aspirin, and venous thromboembolism in women with endometrial cancerKoji Matsuo, Marianne S Hom, Akira Yabuno, et al.
Scientific Reports|October 29, 2020
Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinomaAkira Yabuno, Hirokazu Matsushita, Tetsutaro Hamano, et al.
Gynecologic Oncology|April 2, 2018
Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancerKoji Matsuo, Akira Yabuno, Marianne S Hom, et al.
Gynecologic Oncology|May 29, 2020
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275Julian C Schink, Virginia Filiaci, Helen Q Huang, et al.
Journal for Immunotherapy of Cancer|May 29, 2020
Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinomaHirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, et al.
Gynecologic Oncology|August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerKoji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Pageof 3